F953-0939 Screening compound: N-(1-benzylpiperidin-4-yl)-5-(3,5-dimethyl-1-benzofuran-2-yl)-1,3,4-oxadiazole-2-carboxamide

F953-0939 Screening compound: N-(1-benzylpiperidin-4-yl)-5-(3,5-dimethyl-1-benzofuran-2-yl)-1,3,4-oxadiazole-2-carboxamide
F953-0939 Screening compound: N-(1-benzylpiperidin-4-yl)-5-(3,5-dimethyl-1-benzofuran-2-yl)-1,3,4-oxadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F953-0939
N-(1-benzylpiperidin-4-yl)-5-(3,5-dimethyl-1-benzofuran-2-yl)-1,3,4-oxadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F953-0939

Molecular Formula

C25H26N4O3 (C25 H26 N4 O3)

Compound Name

N-(1-benzylpiperidin-4-yl)-5-(3,5-dimethyl-1-benzofuran-2-yl)-1,3,4-oxadiazole-2-carboxamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-5-(35-dimethyl-1-benzofuran-2-yl)-134-oxadiazole-2-carboxamide

SMILES

Cc1c(-c2nnc(C(NC3CCN(Cc4ccccc4)CC3)=O)o2)oc2c1cc(C)cc2

InChI

InChI=1S/C25H26N4O3/c1-16-8-9-21-20(14-16)17(2)22(31-21)24-27-28-25(32-24)23(30)26-19-10-12-29(13-11-19)15-18-6-4-3-5-7-18/h3-9,14,19H,10-13,15H2,1-2H3,(H,26,30)

InChI Key

UWEDUXZHPAEFHJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27206157

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.071

Distribution Coefficient, logD

2.625

Water Solubility, LogSw

-3.97

Polar Surface Area

66.959

Acid Dissociation Constant (pKa)

14.94

Base Dissociation Constant (pKb)

8.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

F953-0939 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F953-0939 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F953-0939?
Check Price and Availability of F953-0939, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F953-0939 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F953-0939
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F953-0939
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F953-0939 available by request